Low-molecular-weight heparin versus unfractionated heparin in acute ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with drug-eluting stents
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Li, Yong-Jian | - |
dc.contributor.author | Rha, Seung-Woon | - |
dc.contributor.author | Chen, Kang-Yin | - |
dc.contributor.author | Poddar, Kanhaiya L. | - |
dc.contributor.author | Jin, Zhe | - |
dc.contributor.author | Minami, Yoshiyasu | - |
dc.contributor.author | Wang, Lin | - |
dc.contributor.author | Dang, Qun | - |
dc.contributor.author | Li, Guang-Ping | - |
dc.contributor.author | Ramasamy, Sureshkumar | - |
dc.contributor.author | Park, Ji-Young | - |
dc.contributor.author | Choi, Chol Ung | - |
dc.contributor.author | Kim, Jin-Won | - |
dc.contributor.author | Kim, Eung Ju | - |
dc.contributor.author | Park, Chang Gyu | - |
dc.contributor.author | Seo, Hong Seog | - |
dc.contributor.author | Oh, Dong Joo | - |
dc.contributor.author | Jeong, Myung Ho | - |
dc.contributor.author | Ahn, Young Keun | - |
dc.contributor.author | Hong, Taek Jong | - |
dc.contributor.author | Park, Jong-Seon | - |
dc.contributor.author | Kim, Young Jo | - |
dc.contributor.author | Hur, Seung Ho | - |
dc.contributor.author | Seong, In Whan | - |
dc.contributor.author | Chae, Jei Keon | - |
dc.contributor.author | Cho, Myeong Chan | - |
dc.contributor.author | Bae, Jang Ho | - |
dc.contributor.author | Choi, Dong Hoon | - |
dc.contributor.author | Jang, Yang Soo | - |
dc.contributor.author | Chae, In Ho | - |
dc.contributor.author | Kim, Hyo Soo | - |
dc.contributor.author | Kim, Chong Jin | - |
dc.contributor.author | Yoon, Jung Han | - |
dc.contributor.author | Ahn, Tae Hoon | - |
dc.contributor.author | Tahk, Seung-Jea | - |
dc.contributor.author | Chung, Wook Sung | - |
dc.contributor.author | Seung, Ki Bae | - |
dc.contributor.author | Park, Seung Jung | - |
dc.date.accessioned | 2021-09-08T03:59:52Z | - |
dc.date.available | 2021-09-08T03:59:52Z | - |
dc.date.created | 2021-06-11 | - |
dc.date.issued | 2010-04 | - |
dc.identifier.issn | 0002-8703 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/116657 | - |
dc.description.abstract | Background Whether low-molecular-weight heparin (LMWH) is superior to unfractionated heparin (UFH) in acute ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI) with drug-eluting stents (DESs) remains unclear. Methods A total of 3,372 STEMI patients who underwent primary PCI with DESs received either LMWH (n = 1,531 patients, subcutaneous enoxaparin 1 mg/kg, bid for 3-5 days plus reduced dose of UFH [ 50 U/kg] during PCI) or UFH alone (n = 1,841 patients, intravenous bolus injection of 5,000 U, followed by 24,000 U/d infusion for at least 48 hours). The bleeding events and clinical outcomes during in-hospital and at 8 months were compared. Results The incidences of major and minor bleeding events were similar between the 2 groups. Multivariable Cox regression analysis showed that LMWH group had lower incidences of cardiac death (adjusted odds ratio [OR] 0.55, 95% CI 0.39-0.77, P<.001), total death (adjusted OR 0.50, 95% CI 0.37-0.68, P<.001), and total major adverse cardiac events (adjusted OR 0.77, 95% CI 0.62-0.95, P=.017) at 8 months as compared with UFH group. Similar results were obtained across different subgroups including different DESs, age, and sex. Conclusions The LMWH enoxaparin combined with reduced dose of UFH (50 U/kg) administration as an adjunctive antithrombotic therapy in STEMI patients undergoing primary PCI with DESs seems to be safe and efficacious. However, randomized clinical trials are needed to confirm this conclusion. (Am Heart J 2010; 159: 684-690. e1.) | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | MOSBY-ELSEVIER | - |
dc.subject | RANDOMIZED-TRIALS | - |
dc.subject | CLINICAL-PRACTICE | - |
dc.subject | PLATELET-FUNCTION | - |
dc.subject | ENOXAPARIN | - |
dc.subject | THROMBOSIS | - |
dc.subject | THERAPY | - |
dc.subject | METAANALYSIS | - |
dc.subject | ANGIOPLASTY | - |
dc.subject | CLOPIDOGREL | - |
dc.subject | EFFICACY | - |
dc.title | Low-molecular-weight heparin versus unfractionated heparin in acute ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with drug-eluting stents | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Rha, Seung-Woon | - |
dc.contributor.affiliatedAuthor | Choi, Chol Ung | - |
dc.contributor.affiliatedAuthor | Kim, Jin-Won | - |
dc.contributor.affiliatedAuthor | Kim, Eung Ju | - |
dc.contributor.affiliatedAuthor | Park, Chang Gyu | - |
dc.contributor.affiliatedAuthor | Seo, Hong Seog | - |
dc.contributor.affiliatedAuthor | Oh, Dong Joo | - |
dc.identifier.doi | 10.1016/j.ahj.2009.12.041 | - |
dc.identifier.scopusid | 2-s2.0-77950144610 | - |
dc.identifier.wosid | 000276261600025 | - |
dc.identifier.bibliographicCitation | AMERICAN HEART JOURNAL, v.159, no.4, pp.684 - U218 | - |
dc.relation.isPartOf | AMERICAN HEART JOURNAL | - |
dc.citation.title | AMERICAN HEART JOURNAL | - |
dc.citation.volume | 159 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 684 | - |
dc.citation.endPage | U218 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
dc.subject.keywordPlus | RANDOMIZED-TRIALS | - |
dc.subject.keywordPlus | CLINICAL-PRACTICE | - |
dc.subject.keywordPlus | PLATELET-FUNCTION | - |
dc.subject.keywordPlus | ENOXAPARIN | - |
dc.subject.keywordPlus | THROMBOSIS | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | METAANALYSIS | - |
dc.subject.keywordPlus | ANGIOPLASTY | - |
dc.subject.keywordPlus | CLOPIDOGREL | - |
dc.subject.keywordPlus | EFFICACY | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.